Search results for "Infectious diseases"
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
DEI or DIE?
The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021
Telemedicine's time has arrived
As the need for remote health care expands, medical educators and residents continue to refine the best ways to teach and learn telemedicine.
https://immattersacp.org/archives/2022/09/telemedicines-time-has-arrived.htm
1 Sep 2022
Clinician education, feedback led to fewer inappropriate antibiotics for respiratory tract infections
A stepped-wedge cluster randomized study in 31 primary care practices found that the proportion of visits with an antibiotic prescription decreased from 35.2% to 23.0% after an intervention involving clinician education and monthly peer comparison feedback.
https://immattersacp.org/weekly/archives/2021/07/13/5.htm
13 Jul 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
ATS/IDSA release clinical practice guideline on diagnosing, treating CAP
The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Panel issues updated guidance on ART for HIV treatment, prevention
The recommendations from the International Antiviral Society-USA cover initiation of antiretroviral therapy (ART), switching regimens, ART in older patients with HIV, and HIV and COVID-19, among other topics.
https://immattersacp.org/weekly/archives/2022/12/06/1.htm
6 Dec 2022
New research analyzes COVID-19 outcomes, testing, and experimental treatments
A retrospective report looked at serologic antibody testing, while two case series reports described use of convalescent plasma in critically ill patients with COVID-19 in China.
https://immattersacp.org/weekly/archives/2020/04/07/2.htm
7 Apr 2020
IDSA updates treatment guidelines, while studies identify symptoms in specific age groups
The Infectious Diseases Society of America (IDSA) changed its recommendations on steroids, remdesivir, and other therapies. New research from Europe quantified COVID-19 symptoms in older adults as well as neurological complications.
https://immattersacp.org/weekly/archives/2020/06/30/1.htm
30 Jun 2020